Investing Ideas
/
U.S. Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership

U.S. Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.

19 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
CLNN Clene	US$5.00	5.9%	-15.7%	US$39.8m	US$45.17	PS94.8x	E59.2%	n/a
OSTX OS Therapies	US$4.70	24.3%	n/a	US$109.6m	US$12.33	PE-13.5x	E14.7%	n/a
CORT Corcept Therapeutics	US$50.85	-0.1%	56.6%	US$5.5b	US$74.90	PE37.9x	E41.4%	n/a
SPRY ARS Pharmaceuticals	US$10.62	-5.2%	93.8%	US$1.0b	US$26.50	PS401.9x	E70.7%	n/a
BFRI Biofrontera	US$1.11	9.9%	-59.9%	US$8.6m	US$11.50	PS0.2x	E72.2%	n/a
NRXP NRx Pharmaceuticals	US$1.53	7.7%	-66.7%	US$18.2m	US$31.67	PE-0.9x	E71.7%	n/a
PRPH ProPhase Labs	US$0.72	13.6%	-84.1%	US$15.2m	US$18.50	PS1.3x	E77.4%	0%
ACER Acer Therapeutics	US$0.80	-5.4%	-30.0%	US$19.7m	n/a	PE-0.5x	E66.2%	n/a
BRTX BioRestorative Therapies	US$1.44	-5.3%	-17.2%	US$10.7m	US$13.00	PS26.4x	E62.9%	n/a
TLSI TriSalus Life Sciences	US$4.96	20.1%	-41.3%	US$147.6m	US$11.64	PS5.6x	E67.4%	n/a
LQDA Liquidia	US$11.51	0.6%	-4.3%	US$979.2m	US$25.30	PS62.4x	E60.6%	n/a
KRYS Krystal Biotech	US$159.80	-0.6%	28.8%	US$4.6b	US$207.78	PE87.8x	E41.2%	n/a
EVAX Evaxion Biotech	US$0.96	5.5%	-86.0%	US$5.9m	US$11.56	PS1.6x	E69.9%	n/a
PLX Protalix BioTherapeutics	US$1.89	9.2%	6.2%	US$134.7m	US$14.00	PS3x	E118.3%	n/a
HROW Harrow	US$33.39	-1.8%	198.1%	US$1.2b	US$59.85	PS7x	E85.3%	n/a
CDXC ChromaDex	US$5.45	2.8%	281.1%	US$422.6m	US$7.96	PE280.9x	E81.8%	n/a
IPA ImmunoPrecise Antibodies	US$0.41	2.5%	-76.1%	US$13.7m	US$5.00	PS0.8x	E75.1%	n/a
CSBR Champions Oncology	US$8.62	6.3%	53.4%	US$114.4m	US$8.00	PS2.2x	E101.4%	n/a
BTMD biote	US$5.91	2.1%	19.6%	US$217.6m	US$9.95	PE25.6x	E68.8%	n/a

Page 1 of 1